Houston, TX, United States of America

Abner Mhashilkar



Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Abner Mhashilkar: Innovating Cancer Treatments from Houston

Introduction

Abner Mhashilkar, an inventive mind based in Houston, TX, has made significant contributions to the field of cancer treatments through his innovative research and patent developments. With two patents to his name, Mhashilkar has focused on harnessing the potential of novel compounds to combat hyperproliferative diseases.

Latest Patents

One of Mhashilkar's latest patents revolves around the use of antihelminthic drugs as a treatment for hyperproliferative diseases. This groundbreaking invention proposes the application of benzimidazole derivatives in treating tumors, particularly p53-positive ones. By inducing p53 expression and increasing its half-life, these derivatives result in the apoptotic death of tumor cells, showing promise as an effective therapy. In conjunction with p53 gene therapy, the benzimidazole derivatives enhance p53 expression and accumulation in various tumor cells, triggering apoptosis regardless of their p53 status.

Another noteworthy patent from Mhashilkar involves a humanized antibody framework motif. This innovative foundation is encoded by the V gene of K5B8 and the V gene of TR1.6, designed to incorporate the variable region of a tat antibody. Such developments in humanized antibodies potentially open new avenues in therapeutic treatments.

Career Highlights

Abner Mhashilkar has collaborated with prominent institutions, including the University of Texas System, which showcases his ability to work within esteemed research environments. His career has been dedicated to developing stem-cell based therapies and addressing cancer-related challenges through innovative scientific solutions.

Collaborations

Mhashilkar's journey has seen fruitful collaborations, notably with renowned colleagues such as Wayne A. Marasco and Joyce Lavecchio. These partnerships have propelled various research initiatives, enhancing the collective impact on cancer treatment advancements.

Conclusion

In conclusion, Abner Mhashilkar stands out as a pivotal figure in the realm of innovative cancer therapies. His patents not only reflect his dedication to research but also his commitment to improving therapeutic strategies for challenging diseases. Through continued collaboration and inventive prowess, Mhashilkar is poised to contribute significantly to medical advancements in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…